Amendment to co-development and licensing agreement for naproxen and esomeprazole combination for painCo-Development and Licensing Agreement • September 28th, 2021
Contract Type FiledSeptember 28th, 2021Musculoskeletal » Arthritis » Osteoarthritis Musculoskeletal » Arthritis » Rheumatoid arthritis Musculoskeletal » Symptoms » Bone pain Musculoskeletal » Symptoms » Muscular pain Drug delivery